Blood Collection Market By Product (Needles and Syringes, Blood Collection Tubes, Blood Lancets, Blood Bags, Others), By Application (Diagnostics, Treatment), By End User (Hospitals and Diagnostic Centers, Blood Banks, Others): Global Opportunity Analysis
Description
Blood Collection Market By Product (Needles and Syringes, Blood Collection Tubes, Blood Lancets, Blood Bags, Others), By Application (Diagnostics, Treatment), By End User (Hospitals and Diagnostic Centers, Blood Banks, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global blood collection market was valued at $4,775.55 million in 2021, and is projected to reach $7,859.77 million by 2031, registering a CAGR of 5.2% from 2022 to 2031.
Blood is collected as whole blood (WB) by blood donation processes, and later it can be separated into various components by a process called as apheresis. The amount of blood drawn varies and should not be more than 1% of the body weight of the donor. The collection can be done with help of an automated equipment that collects only specific components of blood or also it can be collected manually.
The growth of the blood collection market is driven by increase in incidence of trauma & accidents, increase in number of surgical procedures performed, surge in prevalence of chronic diseases such as blood cancer, and rise in government expenditure on healthcare. Moreover, prevalence of infectious diseases & non-communicable diseases and increase in the number of approvals for technologically advanced products help in the growth of the market. However, the risks related to blood transfusion procedure is expected to hinder the growth of this market. Conversely, the high growth potential in untapped emerging economies is expected to create lucrative opportunities for the market.
The blood collection market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is fragmented into needles & syringes, blood collection tubes, blood lancets, blood bags, and others. On the basis of application, the market is classified into diagnostics and treatment. On the basis of end user, the market is categorized into hospitals & diagnostic centers, blood banks, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key market players operating in this market include, Abbott Laboratories, Becton, Dickinson and Company, FL Medical S.R.L, Greiner Holding AG, Medtronic plc, Narang Medical Limited, Nipro Corporation, Qiagen N.V., Sarstedt AG & Co. KG, Terumo Medical Corporation.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the blood collection market analysis from 2021 to 2031 to identify the prevailing blood collection market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the blood collection market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global blood collection market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Needles and Syringes
Blood Collection Tubes
Blood Lancets
Blood Bags
Others
By Application
Diagnostics
Treatment
By End User
Hospitals and Diagnostic Centers
Blood Banks
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott Laboratories Inc.
Medtronic, Inc.
Becton Dickinson and Company
Terumo Corporation
Nipro Medical Corporation
Qiagen NV
F.L. Medical SRL
greiner holding ag
Haemonetics Corporation
Sarstedt AG
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
The global blood collection market was valued at $4,775.55 million in 2021, and is projected to reach $7,859.77 million by 2031, registering a CAGR of 5.2% from 2022 to 2031.
Blood is collected as whole blood (WB) by blood donation processes, and later it can be separated into various components by a process called as apheresis. The amount of blood drawn varies and should not be more than 1% of the body weight of the donor. The collection can be done with help of an automated equipment that collects only specific components of blood or also it can be collected manually.
The growth of the blood collection market is driven by increase in incidence of trauma & accidents, increase in number of surgical procedures performed, surge in prevalence of chronic diseases such as blood cancer, and rise in government expenditure on healthcare. Moreover, prevalence of infectious diseases & non-communicable diseases and increase in the number of approvals for technologically advanced products help in the growth of the market. However, the risks related to blood transfusion procedure is expected to hinder the growth of this market. Conversely, the high growth potential in untapped emerging economies is expected to create lucrative opportunities for the market.
The blood collection market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is fragmented into needles & syringes, blood collection tubes, blood lancets, blood bags, and others. On the basis of application, the market is classified into diagnostics and treatment. On the basis of end user, the market is categorized into hospitals & diagnostic centers, blood banks, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key market players operating in this market include, Abbott Laboratories, Becton, Dickinson and Company, FL Medical S.R.L, Greiner Holding AG, Medtronic plc, Narang Medical Limited, Nipro Corporation, Qiagen N.V., Sarstedt AG & Co. KG, Terumo Medical Corporation.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the blood collection market analysis from 2021 to 2031 to identify the prevailing blood collection market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the blood collection market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global blood collection market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Needles and Syringes
Blood Collection Tubes
Blood Lancets
Blood Bags
Others
By Application
Diagnostics
Treatment
By End User
Hospitals and Diagnostic Centers
Blood Banks
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott Laboratories Inc.
Medtronic, Inc.
Becton Dickinson and Company
Terumo Corporation
Nipro Medical Corporation
Qiagen NV
F.L. Medical SRL
greiner holding ag
Haemonetics Corporation
Sarstedt AG
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Table of Contents
236 Pages
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: BLOOD COLLECTION MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Needles and Syringes
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Blood Collection Tubes
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.4 Blood Lancets
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- 4.5 Blood Bags
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market share analysis by country
- 4.6 Others
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market share analysis by country
- CHAPTER 5: BLOOD COLLECTION MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Diagnostics
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3 Treatment
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- CHAPTER 6: BLOOD COLLECTION MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals and Diagnostic Centers
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3 Blood Banks
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country
- CHAPTER 7: BLOOD COLLECTION MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Key market trends, growth factors and opportunities
- 7.2.5.1.2 Market size and forecast, by Product
- 7.2.5.1.3 Market size and forecast, by Application
- 7.2.5.1.4 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Key market trends, growth factors and opportunities
- 7.2.5.2.2 Market size and forecast, by Product
- 7.2.5.2.3 Market size and forecast, by Application
- 7.2.5.2.4 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Key market trends, growth factors and opportunities
- 7.2.5.3.2 Market size and forecast, by Product
- 7.2.5.3.3 Market size and forecast, by Application
- 7.2.5.3.4 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Key market trends, growth factors and opportunities
- 7.3.5.1.2 Market size and forecast, by Product
- 7.3.5.1.3 Market size and forecast, by Application
- 7.3.5.1.4 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Key market trends, growth factors and opportunities
- 7.3.5.2.2 Market size and forecast, by Product
- 7.3.5.2.3 Market size and forecast, by Application
- 7.3.5.2.4 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Key market trends, growth factors and opportunities
- 7.3.5.3.2 Market size and forecast, by Product
- 7.3.5.3.3 Market size and forecast, by Application
- 7.3.5.3.4 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Key market trends, growth factors and opportunities
- 7.3.5.4.2 Market size and forecast, by Product
- 7.3.5.4.3 Market size and forecast, by Application
- 7.3.5.4.4 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Key market trends, growth factors and opportunities
- 7.3.5.5.2 Market size and forecast, by Product
- 7.3.5.5.3 Market size and forecast, by Application
- 7.3.5.5.4 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Key market trends, growth factors and opportunities
- 7.3.5.6.2 Market size and forecast, by Product
- 7.3.5.6.3 Market size and forecast, by Application
- 7.3.5.6.4 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Key market trends, growth factors and opportunities
- 7.4.5.1.2 Market size and forecast, by Product
- 7.4.5.1.3 Market size and forecast, by Application
- 7.4.5.1.4 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Key market trends, growth factors and opportunities
- 7.4.5.2.2 Market size and forecast, by Product
- 7.4.5.2.3 Market size and forecast, by Application
- 7.4.5.2.4 Market size and forecast, by End User
- 7.4.5.3 Australia
- 7.4.5.3.1 Key market trends, growth factors and opportunities
- 7.4.5.3.2 Market size and forecast, by Product
- 7.4.5.3.3 Market size and forecast, by Application
- 7.4.5.3.4 Market size and forecast, by End User
- 7.4.5.4 India
- 7.4.5.4.1 Key market trends, growth factors and opportunities
- 7.4.5.4.2 Market size and forecast, by Product
- 7.4.5.4.3 Market size and forecast, by Application
- 7.4.5.4.4 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Key market trends, growth factors and opportunities
- 7.4.5.5.2 Market size and forecast, by Product
- 7.4.5.5.3 Market size and forecast, by Application
- 7.4.5.5.4 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Key market trends, growth factors and opportunities
- 7.4.5.6.2 Market size and forecast, by Product
- 7.4.5.6.3 Market size and forecast, by Application
- 7.4.5.6.4 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Key market trends, growth factors and opportunities
- 7.5.5.1.2 Market size and forecast, by Product
- 7.5.5.1.3 Market size and forecast, by Application
- 7.5.5.1.4 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Key market trends, growth factors and opportunities
- 7.5.5.2.2 Market size and forecast, by Product
- 7.5.5.2.3 Market size and forecast, by Application
- 7.5.5.2.4 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Key market trends, growth factors and opportunities
- 7.5.5.3.2 Market size and forecast, by Product
- 7.5.5.3.3 Market size and forecast, by Application
- 7.5.5.3.4 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Key market trends, growth factors and opportunities
- 7.5.5.4.2 Market size and forecast, by Product
- 7.5.5.4.3 Market size and forecast, by Application
- 7.5.5.4.4 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Abbott Laboratories Inc.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Medtronic, Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Becton Dickinson and Company
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Terumo Corporation
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Nipro Medical Corporation
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Qiagen NV
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 F.L. Medical SRL
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 greiner holding ag
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Haemonetics Corporation
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Sarstedt AG
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 2. BLOOD COLLECTION MARKET FOR NEEDLES AND SYRINGES, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 3. BLOOD COLLECTION MARKET FOR NEEDLES AND SYRINGES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 4. BLOOD COLLECTION MARKET FOR BLOOD COLLECTION TUBES, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 5. BLOOD COLLECTION MARKET FOR BLOOD COLLECTION TUBES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 6. BLOOD COLLECTION MARKET FOR BLOOD LANCETS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 7. BLOOD COLLECTION MARKET FOR BLOOD LANCETS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 8. BLOOD COLLECTION MARKET FOR BLOOD BAGS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 9. BLOOD COLLECTION MARKET FOR BLOOD BAGS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 10. BLOOD COLLECTION MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 11. BLOOD COLLECTION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 12. GLOBAL BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 13. BLOOD COLLECTION MARKET FOR DIAGNOSTICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 14. BLOOD COLLECTION MARKET FOR DIAGNOSTICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 15. BLOOD COLLECTION MARKET FOR TREATMENT, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 16. BLOOD COLLECTION MARKET FOR TREATMENT, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 17. GLOBAL BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 18. BLOOD COLLECTION MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 19. BLOOD COLLECTION MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 20. BLOOD COLLECTION MARKET FOR BLOOD BANKS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 21. BLOOD COLLECTION MARKET FOR BLOOD BANKS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 22. BLOOD COLLECTION MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 23. BLOOD COLLECTION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 24. BLOOD COLLECTION MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 25. NORTH AMERICA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 26. NORTH AMERICA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 27. NORTH AMERICA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 28. NORTH AMERICA BLOOD COLLECTION MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 29. U.S. BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 30. U.S. BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 31. U.S. BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 32. CANADA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 33. CANADA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 34. CANADA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 35. MEXICO BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 36. MEXICO BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 37. MEXICO BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 38. EUROPE BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 39. EUROPE BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 40. EUROPE BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 41. EUROPE BLOOD COLLECTION MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 42. GERMANY BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 43. GERMANY BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 44. GERMANY BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 45. FRANCE BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 46. FRANCE BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 47. FRANCE BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 48. UK BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 49. UK BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 50. UK BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 51. ITALY BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 52. ITALY BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 53. ITALY BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 54. SPAIN BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 55. SPAIN BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 56. SPAIN BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 57. REST OF EUROPE BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 58. REST OF EUROPE BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 59. REST OF EUROPE BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 60. ASIA-PACIFIC BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 61. ASIA-PACIFIC BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 62. ASIA-PACIFIC BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 63. ASIA-PACIFIC BLOOD COLLECTION MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 64. JAPAN BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 65. JAPAN BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 66. JAPAN BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 67. CHINA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 68. CHINA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 69. CHINA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 70. AUSTRALIA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 71. AUSTRALIA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 72. AUSTRALIA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 73. INDIA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 74. INDIA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 75. INDIA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 76. SOUTH KOREA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 77. SOUTH KOREA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 78. SOUTH KOREA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 79. REST OF ASIA-PACIFIC BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 80. REST OF ASIA-PACIFIC BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 81. REST OF ASIA-PACIFIC BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 82. LAMEA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 83. LAMEA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 84. LAMEA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 85. LAMEA BLOOD COLLECTION MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 86. BRAZIL BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 87. BRAZIL BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 88. BRAZIL BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 89. SAUDI ARABIA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 90. SAUDI ARABIA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 91. SAUDI ARABIA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 92. SOUTH AFRICA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 93. SOUTH AFRICA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 94. SOUTH AFRICA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 95. REST OF LAMEA BLOOD COLLECTION MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
- TABLE 96. REST OF LAMEA BLOOD COLLECTION MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 97. REST OF LAMEA BLOOD COLLECTION MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 98.ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT
- TABLE 99.ABBOTT LABORATORIES INC.: OPERATING SEGMENTS
- TABLE 100.ABBOTT LABORATORIES INC.: PRODUCT PORTFOLIO
- TABLE 101.ABBOTT LABORATORIES INC.: NET SALES
- TABLE 102.ABBOTT LABORATORIES INC.: KEY STRATERGIES
- TABLE 103.MEDTRONIC, INC.: COMPANY SNAPSHOT
- TABLE 104.MEDTRONIC, INC.: OPERATING SEGMENTS
- TABLE 105.MEDTRONIC, INC.: PRODUCT PORTFOLIO
- TABLE 106.MEDTRONIC, INC.: NET SALES
- TABLE 107.MEDTRONIC, INC.: KEY STRATERGIES
- TABLE 108.BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 109.BECTON DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 110.BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 111.BECTON DICKINSON AND COMPANY: NET SALES
- TABLE 112.BECTON DICKINSON AND COMPANY: KEY STRATERGIES
- TABLE 113.TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 114.TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 115.TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 116.TERUMO CORPORATION: NET SALES
- TABLE 117.TERUMO CORPORATION: KEY STRATERGIES
- TABLE 118.NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT
- TABLE 119.NIPRO MEDICAL CORPORATION: OPERATING SEGMENTS
- TABLE 120.NIPRO MEDICAL CORPORATION: PRODUCT PORTFOLIO
- TABLE 121.NIPRO MEDICAL CORPORATION: NET SALES
- TABLE 122.NIPRO MEDICAL CORPORATION: KEY STRATERGIES
- TABLE 123.QIAGEN NV: COMPANY SNAPSHOT
- TABLE 124.QIAGEN NV: OPERATING SEGMENTS
- TABLE 125.QIAGEN NV: PRODUCT PORTFOLIO
- TABLE 126.QIAGEN NV: NET SALES
- TABLE 127.QIAGEN NV: KEY STRATERGIES
- TABLE 128.F.L. MEDICAL SRL: COMPANY SNAPSHOT
- TABLE 129.F.L. MEDICAL SRL: OPERATING SEGMENTS
- TABLE 130.F.L. MEDICAL SRL: PRODUCT PORTFOLIO
- TABLE 131.F.L. MEDICAL SRL: NET SALES
- TABLE 132.F.L. MEDICAL SRL: KEY STRATERGIES
- TABLE 133.GREINER HOLDING AG: COMPANY SNAPSHOT
- TABLE 134.GREINER HOLDING AG: OPERATING SEGMENTS
- TABLE 135.GREINER HOLDING AG: PRODUCT PORTFOLIO
- TABLE 136.GREINER HOLDING AG: NET SALES
- TABLE 137.GREINER HOLDING AG: KEY STRATERGIES
- TABLE 138.HAEMONETICS CORPORATION: COMPANY SNAPSHOT
- TABLE 139.HAEMONETICS CORPORATION: OPERATING SEGMENTS
- TABLE 140.HAEMONETICS CORPORATION: PRODUCT PORTFOLIO
- TABLE 141.HAEMONETICS CORPORATION: NET SALES
- TABLE 142.HAEMONETICS CORPORATION: KEY STRATERGIES
- TABLE 143.SARSTEDT AG: COMPANY SNAPSHOT
- TABLE 144.SARSTEDT AG: OPERATING SEGMENTS
- TABLE 145.SARSTEDT AG: PRODUCT PORTFOLIO
- TABLE 146.SARSTEDT AG: NET SALES
- TABLE 147.SARSTEDT AG: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.BLOOD COLLECTION MARKET SEGMENTATION
- FIGURE 2.BLOOD COLLECTION MARKET,2021-2031
- FIGURE 3.BLOOD COLLECTION MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.BLOOD COLLECTION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.BLOOD COLLECTION MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NEEDLES AND SYRINGES BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BLOOD COLLECTION TUBES BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF BLOOD LANCETS BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BLOOD BAGS BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 18.BLOOD COLLECTION MARKET,BY APPLICATION,2021(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTICS BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF TREATMENT BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 21.BLOOD COLLECTION MARKET,BY END USER,2021(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND DIAGNOSTIC CENTERS BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF BLOOD BANKS BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS BLOOD COLLECTION MARKET,2021-2031(%)
- FIGURE 25.BLOOD COLLECTION MARKET BY REGION,2021
- FIGURE 26.U.S. BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 31.UK BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 33.SPAIN BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EUROPE BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 35.JAPAN BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 36.CHINA BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 37.AUSTRALIA BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 38.INDIA BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH KOREA BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 40.REST OF ASIA-PACIFIC BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 41.BRAZIL BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 42.SAUDI ARABIA BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 43.SOUTH AFRICA BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 44.REST OF LAMEA BLOOD COLLECTION MARKET,2021-2031($MILLION)
- FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49.COMPETITIVE DASHBOARD
- FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 51.ABBOTT LABORATORIES INC..: NET SALES ($MILLION)
- FIGURE 52.MEDTRONIC, INC..: NET SALES ($MILLION)
- FIGURE 53.BECTON DICKINSON AND COMPANY.: NET SALES ($MILLION)
- FIGURE 54.TERUMO CORPORATION.: NET SALES ($MILLION)
- FIGURE 55.NIPRO MEDICAL CORPORATION.: NET SALES ($MILLION)
- FIGURE 56.QIAGEN NV.: NET SALES ($MILLION)
- FIGURE 57.F.L. MEDICAL SRL.: NET SALES ($MILLION)
- FIGURE 58.GREINER HOLDING AG.: NET SALES ($MILLION)
- FIGURE 59.HAEMONETICS CORPORATION.: NET SALES ($MILLION)
- FIGURE 60.SARSTEDT AG.: NET SALES ($MILLION)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
